ESC Premium Access

Taking the initiative: the cardiologist´s perspective

Topic: Risk Factors and Prevention
Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance

Congress Presentation

About the speaker

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
28 presentations
1 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor T. Luscher (London, GB)

Thumbnail

The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes

Speaker: Professor S. Kaul (Los Angeles, US)

Thumbnail

The SGLT2 inhibitor era: what more can we expect?

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Audience questions and answers, summary and close

Speaker: Professor T. Luscher (London, GB)

Thumbnail

Access the full session

SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes

Speakers: Professor N. Marx, Professor T. Luscher, Professor S. Kaul, Professor S. Anker, Professor T. Luscher
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk